Enhanced upper genital tract pathologies by blocking Tim-3 and PD-L1 signaling pathways in mice intravaginally

Bo Peng1, Chunxue Lu, Lingli Tang

  • 1Department of Microbiology and Immunology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

BMC Infectious Diseases
|December 16, 2011
PubMed
Abstract

Insights

Blocking Tim-3 and PD-L1 immune checkpoints did not affect chlamydial shedding but worsened upper genital tract inflammation. This suggests these pathways may be targeted to reduce tubal damage in persistent chlamydial infections.

Area of Science:

  • Immunology
  • Microbiology
  • Reproductive Health

Background:

  • T-cell immunoglobulin and mucin-domain containing-3 (Tim-3) and programmed death-ligand 1 (PD-L1) are key negative regulators of immune responses.
  • The specific roles of Tim-3 and PD-L1 in chlamydial infections remain largely uninvestigated.

Purpose of the Study:

  • To evaluate the impact of blocking Tim-3 and PD-L1 signaling on the immune response and pathology during Chlamydia muridarum infection.
  • To determine if targeting these pathways could influence chlamydial clearance or associated inflammation.

Main Methods:

  • Mice were infected intravaginally with C. muridarum.
  • Treatment involved administering neutralization antibodies against Tim-3 and PD-L1.
  • Outcomes measured included live organism shedding, cytokine levels, adaptive immune responses, and upper genital tract inflammatory pathology.

Main Results:

  • Dual antibody blockade of Tim-3 and PD-L1 did not alter the shedding of live chlamydial organisms.
  • Blocking these pathways did not affect lower genital tract cytokine profiles or systemic adaptive immune responses.
  • Significantly enhanced C. muridarum-induced pathologies, such as hydrosalpinx and inflammatory infiltration, were observed in the upper genital tract.

Conclusions:

  • Tim-3 and PD-L1 signaling negatively regulate upper genital tract pathologies during chlamydial infection without compromising anti-chlamydial immunity.
  • Targeting Tim-3 and PD-L1 pathways offers a potential therapeutic strategy to attenuate tubal pathologies in women with persistent C. trachomatis infections.

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Microbiota of the Urogenital Tract01:28

Microbiota of the Urogenital Tract

The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...